Experience of Treating Retinal Venous Occlusion with Anticoagulant and Antisclerosis Therapy

A prospective study of xenon arc photocoagulation for central retinal vein occlusion.

“…None of the patients in the treated group has developed neovascular glaucoma. Between 8 and 48 per cent of patients with central vein occlusion are reported to develop neovascular glaucoma ultimately (Gradle, 1937;Braendstrup, I950;Vannas and Orma, 1957;Raitta, I965). Our preliminary data show that 3600 scatter treatment with xenon photocoagulation may be significant in the prevention of neovascular glaucoma.…”

“…Therapeutic regimens including potassium iodide and pilocarpine (Braendstrup,I950), irradiation (Gradle, I937;Benedict, 1948;Hessberg, 1944), anticoagulants (Holmin and Polman, 1938;Klien and Olwin, I956;Vannas and Orma, 1957), fibrinolytic agents (Dolenek,Blatny,and Navratil,I968; den Ottolander, I968), dextran 40 (Franqois and Verbracken, 1974), corticosteroids (van Loon, I96I; Mehlan, Eichler, and Jenssen, 1974), and carbogen (95 per cent O2, 5 per cent CO.,) (Sedney, 1976) have been advocated.…”

The Causes and Therapy of Thrombosis of the Retinal Veins

“…This favourable finding was corroborated by the American publication of Vannas and Orma (13). They reported two methods: a) Heparine injections followed by oral anti-coagulants for 10-20 days; b) 10-14 days intravenous heparine injections and further vitamins A and E for a long time; during this time, which can last months or years, 100 mg. heparine was given twice a week.…”

On the Treatment of Arteriosclerotic Chorioretinopathy

“…It may be mentioned that we have decided to use a corresponding therapy against thrombosis of the central retinal vein (Vannas & Orma 1957). The majority of these 81 cases had an obvious sclerotic component in the etiology of the thrombosis.…”